Agape ATP Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Agape ATP Corp Company

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. The Company offers four series of products: ATP Zeta Health Program, ENERGETIQUE, BEAUNIQUE and E.A.T.S. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake and unhealthy lifestyles. ENERGETIQUE series consists of the energy mask series, hyaluronic acid and mousse facial cleanser. Its BEAUNIQUE product series focuses on the research of its diet’s impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

Agape ATP Corp Info



Ticker SymbolATPC

Company nameAgape ATP Corp

IPO dateSep 17, 2018

CEODr. Kok Choong How

Number of employees16

Security typeOrdinary Share

Fiscal year-endSep 17

Address1705-1708 Level 17, Tower 2, Faber Tower

CityKUALA LUMPUR

Stock exchangeNASDAQ Capital Market Consolidated

CountryMalaysia

Postal code58100

Phone60327325716

Websitehttps://www.agapeatpgroup.com/index.php/agape-atp-corporation/introduction

Ticker SymbolATPC

IPO dateSep 17, 2018

CEODr. Kok Choong How

Company Executives of Agape ATP Corp



Name

Name/Position

Position

Shareholding

Change

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Dr. John Hing Vong

Deputy Chairman of the Board

--

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Dr. Ni Luh Dharmakert Natih

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Dr. John Hing Vong

Deputy Chairman of the Board

--

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

By BusinessUSD

Name

Revenue

Proportion

Others – Products for the provision of complementary health therapies

218.65K

46.97%

Green energy

135.43K

29.09%

Skin care and healthcare products

55.45K

11.91%

Health and wellness services

39.82K

8.55%

Energized Mineral Concentrate

13.77K

2.96%

Other

2.38K

0.51%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Others – Products for the provision of complementary health therapies

218.65K

46.97%

Green energy

135.43K

29.09%

Skin care and healthcare products

55.45K

11.91%

Health and wellness services

39.82K

8.55%

Energized Mineral Concentrate

13.77K

2.96%

Other

2.38K

0.51%

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Other

67.56%

Shareholders

Proportion

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Other

67.56%

Shareholder Types

Shareholders

Proportion

Corporation

51.32%

Individual Investor

1.97%

Investment Advisor

0.22%

Hedge Fund

0.11%

Other

46.37%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

11

169.49K

0.34%

+157.95K

2025Q2

21

26.66M

53.32%

+25.19M

2025Q1

20

26.65M

53.30%

+25.18M

2024Q4

10

1.46M

38.16%

+37.54K

2024Q3

10

1.42M

37.02%

+15.86K

2024Q2

9

1.40M

36.53%

-3.05K

2024Q1

8

1.40M

36.61%

+7.38K

2023Q4

3

1.39M

36.38%

+578.00

2023Q3

2

1.39M

36.92%

--

2023Q2

2

3.48M

39.27%

--

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Lesser Panda Ltd

3.68M

7.36%

+3.68M

--

Mar 24, 2025

Global Fartech Ltd

3.45M

6.9%

+3.45M

--

Mar 24, 2025

Nexus Investments Group Ltd

3.04M

6.07%

+3.04M

--

Mar 24, 2025

Oceanic Equity Partner Ltd

3.03M

6.06%

+3.03M

--

Mar 24, 2025

Blue Horizon Capital Ltd

3.03M

6.05%

+3.03M

--

Mar 24, 2025

Global Ascend Ventures Ltd

3.02M

6.04%

+3.02M

--

Mar 24, 2025

Vanguard Development Holdings Ltd

3.02M

6.03%

+3.02M

--

Mar 24, 2025

Evergreen Strategic Capital Holding Ltd

3.01M

6.03%

+3.01M

--

Mar 24, 2025

Choong (How Kok)

980.45K

1.96%

+574.00

+0.06%

Jan 08, 2025

HKC Talent, Ltd

385.75K

0.77%

-26.50K

-6.43%

Jan 08, 2025

Related ETFs



Name

Proportion

No Data

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Date

Type

Ratio

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1